Fragment-based screening of programmed death ligand 1 (PD-L1)-Reference-Cited by-同舟云学术

Fragment-based screening of programmed death ligand 1 (PD-L1)

Published:2019-03 Issue:6 Volume:29 Page:786-790
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Perry Evan,Mills Jonathan J.,Zhao Bin,Wang Feng,Sun Qi,Christov Plamen P.,Tarr James C.,Rietz Tyson A.,Olejniczak Edward T.,Lee Taekyu,Fesik Stephen^ORCID

Funder

NIH

NSF

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Immune surveillance of tumors;Swann;J Clin Invest,2007

3. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

4. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000

5. The PD-1 pathway in tolerance and autoimmunity;Francisco;Immunol Rev,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and optimization of novel PD-L1 inhibitors and the identification of a highly potent and orally bioavailable PD-L1 inhibitor;European Journal of Medicinal Chemistry;2024-11

2. Determinants of intention to use ChatGPT for obtaining shopping information;Journal of Marketing Theory and Practice;2024-07-26

3. Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies;Bioorganic Chemistry;2024-07

4. An updated patent review on PD-1/PD-L1 antagonists (2022-present);Expert Opinion on Therapeutic Patents;2024-06-25

5. C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction;Molecules;2024-06-04